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ABSTRACT 
Significance. The environment can elicit biological responses such as oxidative stress (OS) and 
inflammation as consequence of chemical, physical or psychological changes. As population 
studies are essential for establishing these environment-organism interactions, biomarkers of 
oxidative stress or inflammation are critical in formulating mechanistic hypotheses.  Recent 
advances. By using examples of stress induced by various mechanisms, we focus on the 
biomarkers that have been used to assess oxidative stress and inflammation in these 
conditions. We discuss the difference between biomarkers that are the result of a chemical 
reaction (such as lipid peroxides or oxidized proteins that are a result of the reaction of 
molecules with reactive oxygen species, ROS) and those that represent the biological 
response to stress, such as the transcription factor NRF2 or inflammation and inflammatory 
cytokines. Critical issues. The high-throughput and holistic approaches to biomarker 
discovery used extensively in large-scale molecular epidemiological exposome are also 
discussed in the context of human exposure to environmental stressors. Future directions. 
We propose to consider the role of biomarkers as signs and distinguish between signs that 
are just indicators of biological processes and proxies that one can interact with and modify 
the disease process. 
 
KEY WORDS 
 
Exposome; nanomaterials; cytokines; proteomics; genomics; NRF2, xenobiotics; emotions; 
neuroendocrinology 
  
 4 
BIOMARKERS OF INFLAMMATION AND OXIDATIVE STRESS (OS).  
 
The theory that OS - an unbalance between production of toxic oxygen species, reactive 
oxygen species (ROS) and endogenous antioxidants (164) -may be at the basis of a disease 
has been first put forward by Harman in 1956 with the “free radical theory of aging”, in which 
he concluded “This theory is suggestive of chemical means of prolonging effective life “(64). 
Despite this, there are no antioxidants currently approved by regulatory agencies for any 
disease (59) 
, with the possible exception of edaravone, an antioxidant approved in Japan and India for 
aiding neuroprotection in stroke patients (96). 
Inflammation is also postulated as a pathogenic mechanism in most diseases or as a major 
risk factor (44). Its oldest definition is by Aulus Cornelius Celsus in the first century AD, who 
defined the four hallmarks of inflammation: “rubor, et tumor, cum calore, et dolore”, redness, 
swelling, heat and pain (29). These are, for Celsus, “notae vero inflammationis”. “Notae” is 
usually translated in English with “signs” (“the cardinal signs of inflammation”). This is our 
first encounter, in our review, of the concept of biomarker. In a way, biomarkers are “signs”. 
The father of semiotic, Charles Sanders Peirce, described a semiotic triad where he defines 
the relationship between a sign, the object it stands for and the interpretant (9). This concept 
is shown in Figure 1 where when the interpretant sees smoke, she knows that that sign 
indicates that somewhere there is a wildfire.  
From Celsus’ perspective, the signs of inflammation were viewed mainly with a diagnostic or 
classification purpose. However, in clinical and preclinical studies, as well as in 
epidemiological studies, biomarkers are also used to gain insights into the causal mechanisms 
underlying diseases. Biomarkers have been classified in biomarkers for the aetiology of the 
disease (risk factors; including biomarkers of exposure), and biomarkers of disease used in 
the screening or diagnosis, or to monitor disease progression (prognosis) (116). Even if not 
implicit in their definition, one desirable criterion for a biomarker is to be accessible - i.e. 
measurable in biological fluids that can be obtained in a minimally-invasive manner (such as 
urine, blood or synovial fluid). In animal models, biomarkers can also be measured in tissues 
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and organs, possible only in human patients in the few cases where biopsy samples are 
obtained for diagnostic purposes. 
The study of diseases can, in its turn, lead to the definition of new biomarkers and to the 
refinement of the criteria for disease classification. For instance, an inflammatory response 
often results in tissue damage (e.g. joint damage in arthritis) and loss of function, the “functio 
laesa” described by Galen (145). The study of the molecular mechanisms of inflammation led 
to infiltration of white blood cells, their recruitment in the tissues as a result of inflammatory 
mediators known as chemokines (197), being considered as additional criterion of 
inflammation, more than the classical cardinal signs. Cytokines and chemokines, 
inflammatory mediators causative of many features of inflammatory diseases, including the 
old five cardinal signs, are now used as biomarkers of inflammation. 
The identification of cytokines as mediators of inflammation in the mid 1980s led to what 
Tracey called the “cytokine theory of disease” (176).  Contrary to the OS theory of disease, 
this led to major advances in the treatment of chronic inflammatory diseases, and less than 
15 years after the identification of the cytokine tumor necrosis factor-α (TNF-α), anti-TNF-α 
antibodies were approved in the therapy of chronic inflammatory diseases and are now the 
top-selling biologicals.  
Here we review both biomarkers of OS and inflammation; not a random choice, as the two 
fields are tightly linked. ROS can activate the transcription factor NF-NB (156), which has many 
inflammatory cytokines among its target genes. Conversely, inflammation can induce OS 
(147), as for instance in the case of ROS production by polymorphonuclear neutrophils (125). 
Although the two pathways are so intertwined, they present entirely different challenges in 
terms of biomarkers. When studying disease mechanisms, we want to be able to measure the 
effectors of inflammation. The development of anti-TNF-α drugs was possible as researchers 
could measure TNF-α levels in patient with commercially available immunoassays that detect 
TNF-α in stored blood samples. 
All this is very difficult when studying OS in disease. Here the effector molecules are ROS, 
which have short half-lives, ranging from nanoseconds to milliseconds (85). This makes it 
impossible to measure ROS in biological samples and we must rely on signs, chemicals that 
are produced by the interaction of ROS with various cellular molecules (57). 
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Another important aspect to consider is the difference between biomarkers that are 
measuring the formation of the effector molecule and those that measure the response of 
the organism to an inflammatory stimulus; inflammation is a defence/repair reaction of the 
organism to an infection or injury. The process is complex, as the effector cytokines in 
inflammation are produced after a series of steps. As we mentioned above, there are several 
biomarkers of OS that indicate the exposure of the organism to ROS by measuring oxidative 
breakdown products of cellular molecules. However, exposure to OS can be inferred by 
measuring the cellular defence response to it and, in this review, we will give the example of 
the transcription factor nrf2/antioxidant response element (ARE) transcription factor that is 
activated by ROS and other electrophiles. There are many ways environmental stressors 
induce disease by common pathways (39,123). The sections in this review will deal with 
psychological, environmental or noise-induced stress, trying to focus on how their effects on 
inflammation or OS were detected. 
 
ENGINEERED NANOMATERIALS AS ENVIRONMENTALLY-BORNE AGENTS INDUCING 
INFLAMMATION AND OS 
 
Engineered nanomaterials (ENM) are manufactured materials in which at least one dimension 
is in the nanometer-range (< 100 nm). The higher surface area increases the material’s 
reactivity (126). Redox interactions of ENM is a major mechanism of toxicity, particularly for 
metal and metal oxide nanomaterials, quantum dots and carbon nanotubes (CNT). 
Typically, OS is induced by ENM in a three-tiered hierarchical sequence (Figure 2) (126,131). 
A mild production of ROS induced by ENM (Tier 1) lowers the reduced glutathione (GSH) / 
oxidized GSH (GSSG) ratio and upregulates genes encoding type II anti-oxidant enzymes, thus 
re-establishing homeostasis. In Tier 2, the defensive reaction is more complex, ENM induce 
the production of ROS triggering the production of inflammatory cytokines and chemokines. 
However, the inflammatory response is transient, as the elimination of the triggering event 
(e.g., the phagocytosed ENM) and inflammation-damping feedback mechanisms re-establish 
homeostasis. In Tier 3, the GSH/GSSG ratio is completely unbalanced and essential 
components of cells are damaged, causing genotoxicity and cytotoxicity. 
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This sequence does not distinguish between the capacity of ENM to generate ROS in cell-free 
systems (131) and ROS generation consequent to nano-bio interaction. In a complex system 
(tissue, organ) a different three-pronged model can be proposed for the inflammatory 
response to ENM (Figure 3). In this model, Prong 1 represents the lack of response, due to 
either “ignorance” or “tolerance”, in which the living system eliminates ENM immediately, 
e.g. by excretion with urine. Prong 2 is the classical protective inflammatory response, in 
which a tissue reacts to ENM sending alarm signals, with recruitment of blood immune cells 
to eliminate the ENM. The reaction is, however, limited in time and circumscribed; after 
eliminating the ENM, inflammation resolves. Prong 3 is the pathological situation of an 
inflammatory reaction that cannot resolve, as in the case of persistent materials (e.g., fiber-
like particles).  This may result in persistent inflammation with tissue destruction and 
development of non-functional neo-tissue (granuloma, scarring tissue, pannus, fibrotic 
tissue). Only Prong 3 can be eventually harmful for the organism and cause irreparable 
damage.  
The three-tiered model of ENM-induced OS does not reflect the three-pronged model of 
ENM-induced inflammation because the entire organism considers the death of single cells 
as an acceptable event that may be important in the “cleaning” and healing reaction.  
 
ROS production by nanomaterials 
Unstable ENM can undergo oxidation, reduction and dissolution in biological media, releasing 
reactive free ions (in the case of metal ENM such as silver), or excitation of electrons and 
generation of ROS (as in the case of titania ENM and fullerenes upon UV irradiation). In 
addition, the reactive surface of ENM may absorb transition metals that catalyze ROS-
generating reactions (Fenton, Fenton-like, Haber-Weiss) and produce cytotoxic and genotoxic 
hydroxyl radicals (126,131,137). Production of ROS resulting from the interaction of ENM with 
living systems is mainly indirect, due to damage or alterations caused by ENM to membranes, 
which trigger an alarm inflammatory reaction. The production of ROS is one of the defensive 
mechanisms initiated by innate defense cells such as phagocytes, aiming at killing 
microorganisms. Silica and polycationic particles can interact with plasma membrane 
phospholipids leading to membrane destabilization and ROS production (3,103). Urate 
crystals can also bind plasma membrane cholesterol and lead to aggregation of receptors and 
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other molecules within lipid rafts, thus activating Syk-dependent inflammatory signaling and 
ROS generation (128,202). ROS induction can also be indirect, as for instance in the case of 
crystalline silica particles that can induce TNF-α production that stimulates ROS generation 
(15). Once internalized, ENM can destabilize and rupture the membranes of organelles such 
as phagolysosomes and mitochondria, causing ROS production and inflammation. 
High-aspect ratio ENM (rigid fiber-like or needle-like ENM) are particularly challenging for 
phagocytes and generate a phenomenon known as “frustrated phagocytosis”, with waves of 
phagocytes attempting to take up the material, and persistent inflammation, including ROS 
production. ROS production induced by ENM is in most cases associated with Akt/mTOR 
pathway, autophagy and apoptosis (5). This can evolve into a Tier 3 reaction, with ROS 
production inducing lipid peroxidation, membrane destabilization, DNA and protein damage. 
Rigid needle-like ENM can also cause phagocyte death by literally perforating the cell 
membrane (121).  
Unlike apoptosis, necrotic cell death implies membrane damage and release of intracellular 
components, which perpetuates the inflammatory reaction (187). This may lead to tissue 
damage or, in a “pathological” attempt to contain the danger, can result in fibrotic or 
granulomatous reactions (Prong 3). In some cases, leukocytes can successfully degrade high-
aspect ratio EMN without phagocytosing them, as in the case of multi-walled CNT, which are 
sensitive to several leukocytic enzymes, and can therefore be eliminated rapidly without 
causing excessive ROS-mediated tissue damage (183). This would therefore be a classical 
Prong 2 inflammatory reaction that resolves without causing permanent damages. 
 
Inflammatory reactions induced by nanomaterials 
Inflammation (Prong 2) is therefore a central event in ENM-induced OS (24). At the organism 
level, inflammation is a defensive mechanism, which succeeds in tagging and eliminating 
potentially dangerous agents (including ENM). Inflammation however always induces some 
collateral damage, i.e. the death of some cells (including both the effector cells and innocent 
bystanders). In terms of ENM cytotoxicity, at the single-cell level inflammation can be in Tier 
2 (resolves without cell death) or in Tier 3 (ending with cell death). Both events can be 
included in Prong 2, an inflammatory reaction at the tissue/organ/organism level that 
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succeeds in eliminating the danger despite some cell death and tissue damage, and succeeds 
in repairing the collateral damage and restore functionality. Tier 2 and Tier 3 cellular 
reactions, on the other hand, are also included in Prong 3, the unresolving inflammation that 
fails in re-establishing tissue homeostasis, so that organ function is eventually compromised. 
One aspect of ENM-induced inflammation is the capacity of activating the inflammasome, in 
particular NLRP3, which is the main inflammasome complex. This is a complex of proteins that 
assembles in the cytoplasm in response to inflammatory stimuli and leads to the activation of 
the enzyme caspase-1, responsible for cleavage and activation of the precursor forms of two 
important inflammatory cytokines, IL-1E and IL-18 (82). Caspase-1 can also auto-activate and 
mediate cell death (172). Several studies have shown that ENM can activate the NLRP3 
inflammasome (reviewed in (171)), similarly to other particulate agents (e.g. hydroxyapatite 
crystals, cholesterol crystals, and aluminum hydroxide particles) (52,74,83). Inflammasome 
activation by ENM can occur through different mechanisms, including generation of ROS, 
which participate in inflammasome activation (63,190). Another mechanism is the 
destabilization of phagolysosomal membranes with consequent release of lysosomal 
enzymes, in particular cathepsin B, that activate the inflammasome either directly or via ROS 
(82). Other putative mechanisms of ENM-induced inflammasome activation include 
activation of the NADPH oxidases, K+ efflux, purinergic receptor P2X7 (P2X7R)-mediated ATP 
depletion, decrease of mitochondria membrane potential, and thioredoxin-interacting 
protein (TXNIP)-induced NALP3 activation (82,148). A summary of typical data of ENM-
induced NLRP3 inflammasome activation is presented in Table 1. The general conclusion is 
that crystals and high-aspect particles (such as fibers) are excellent activators of the 
inflammasome. However, since inflammasome activation is not per se a sign of toxicity or 
pathological inflammation, it is a reaction that can be included both in Prong 2 and in Prong 
3, and only a deeper kinetic analysis may allow us to discriminate between protective and 
pathological activation. 
A final note of caution, when studying OS and inflammation induced by RNM, regards the 
possibility that ENM are inadvertently contaminated with endotoxin. This is a very common 
event when ENM synthesis and handling are not carried out in endotoxin-free conditions 
(180). The presence of endotoxin can cause per se inflammation that may be erroneously 
attributed to ENM (106). 
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Induction of oxidative stress and inflammation by particulate matter 
All that has been said above for engineered nanomaterials applies as well to particulate 
matter (PM) collected from the environment. Indeed, studies on the capacity of PM to induce 
OS and inflammation are extensive and date back many years. Diesel exhaust particles (DEP), 
concentrated ambient particles (CAP) and ultrafine particles (UFP) are some of the many 
types of PM that have been extensively studied in this direction (see for instance Li et al. 
(105)). Although many studies show that PM can induce significant pulmonary inflammation 
upon inhalation in vivo, still we are unable to associate PM characteristics with the ability to 
induce OS and inflammation. In fact, ambient PM is typically morphologically and chemically 
heterogeneous, very much depending on the specific environmental conditions (such as 
temperature and humidity) and concomitant emissions. In addition, the presence of 
biologically active molecules such as bacterial LPS (see above for ENM) is practically never 
tested in the many studies published so far (see for instance Ying et al. (204)), leaving open 
the possibility that several of the effects caused by PM can be attributed to the presence of 
bacterial moieties, which typically trigger the same OS and inflammatory effects. Thus, the 
PM ability of inducing OS and inflammation is most likely the result of intrinsic toxicity of the 
chemicals present in the PM, of its state of aggregation and consequent changes in 
morphology (which may cause mechanical stress to cells) and of the presence of bystander 
biological substances (such as pollens, animal allergens, bacterial fragments of whole micro-
organisms). In this context, although we can list many biomarkers of both OS and 
inflammation induced by inhalation of PM, it is impossible to associate any of them to 
particle-specific effects.  
 
 
NRF2 AS AN INDICATOR OF RESPONSE TO OS 
 
One approach to monitoring OS as well as environmental electrophilic chemicals is to use 
biomarkers based on the response of the organism, as opposed to measuring oxidized 
products of cellular components. NRF2 is the main transcriptional regulator of cellular 
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homeostasis and protects against multiple stress conditions. Upon dimerization with small 
MAF proteins, it recognizes an enhancer in the promoter region of target genes, termed 
Antioxidant Response Element/Electrophile Responsive Element (ARE/EpRE) genes. These 
account for about 1% of human genome and encode phase I, II and III detoxification enzymes, 
GSH, peroxiredoxin (PRDX) and thioredoxin (TXN) metabolism, intermediary metabolism 
related to pentose phosphate pathway, etc. (67).  
The main mechanism of regulation is protein stability by the ubiquitin/proteasome system 
(UPS) illustrated in Figure 4. Under non-stress conditions, the E3 ubiquitin ligase adapter 
Kelch-like ECH-associated protein 1(KEAP1) drives NRF2 to ubiquitination by the Cul3/RBX 
complex and rapid proteasomal degradation. However, KEAP1 contains several cysteine 
residues which have a low pKa value, making highly suited for acting as a sensor for oxidative 
and electrophilic stress (112). Oxidant or electrophilic modification of critical cysteines in 
KEAP1, mainly C155, C273 and C288, prevent the protein from connecting NRF2 to the UPS, 
thus resulting in the accumulation of nuclear NRF2 and transcriptional activation of ARE 
genes. Another crucial mechanism for control of NRF2 stability is by phosphorylation. Several 
kinases phosphorylate NRF2 with different outcomes. Activating phosphorylation by MAP 
kinases, PKC or PERK at Ser40 and other residues appears to free NRF2 from KEAP1 control. 
On the other hand, the Ser/Thr protein kinase GSK-3 phosphorylates at least Ser 335 and 338 
in murine NRF2 thereby creating a recognition site for the E3 ubiquitin ligase adapter E-TrCP, 
leading to ubiquitination by Cul1/RBX and proteasome degradation of NRF2 (40,141,142). 
Importantly, several phosphatases, such as phosphatase and tensin homolog (PTEN), contain 
thiol reactive cysteines in their catalytic centre, which become inactive upon oxidation or 
reaction with electrophiles (139,149). In this case, PTEN inhibition leads to sustained 
activation of AKT and inhibition of GSK-3. As a result, NRF2 escapes Glycogen synthase kinase 
3 (GSK-3)/E-TrCP mediated degradation (40). Below we will discuss advances on its role for 
protection against several environmental forms of stress. 
 
Heavy metals  
Occupational or environmental exposure to heavy metals generate OS that, depending of the 
route of entrance and clearance, may produce liver, kidney or lung damage among others. 
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Chromium, arsenic, cadmium, mercury, and lead can interact with nucleophilic thiol groups, 
e.g. cysteines residues in proteins. Cells have a thiol buffering capacity represented by the 
GSH and PRDX/TXN systems. Exposure to heavy metals will compromise these systems and 
alter a significant fraction of thiols in critical enzymes. Formation of sulfur-metal bonds in 
redox-sensitive cysteines of KEAP1 will result in its stabilization. Also, signaling pathways are 
altered, with phosphatases such as PTEN being inhibited resulting in increased activation of 
AKT, inhibition of GSK-3 and further stabilization of NRF2. The result is up-regulation of genes 
involved in GSH synthesis and maintenance of reduced TRX and GSH, both important to 
tolerate metal exposure.  
Furthermore, as reported for cadmium, chromium, arsenic and others, low-level chronic 
exposure to metals may induce cancer. Somatic mutations in the interface of interaction 
between KEAP1 and NRF2 have been correlated with several types of tumors (162), and NRF2 
levels are elevated in cancer cells, resulting in a metabolic reprogramming that allows to 
withstand OS and adverse growth conditions. It is therefore possible that part of the 
tumorigenic activity associated with exposure to heavy metals might be due to dysregulation 
of NRF2 (165).  
Most of the exposure to heavy metals is in the form or reactive molecules. For example, 
intracellular reduction of hexavalent chromium generates highly reactive pro-oxidant 
intermediates, together with superoxide, hydrogen peroxide, and hydroxyl radical. These 
compounds irreversibly inhibit TXN reductase and deplete TXN and PRDX (124). While this 
situation is typical of KEAP1 inhibition, it is also recognized that TXN depletion has additional 
effects on signalling pathways such as activation of ASK1, leading to up-regulation of NRF2 by 
MAPK kinases by yet unknown mechanisms.  
 
Noise injury 
As expected, noise-induced oxidative stress also results in the activation of NRF2 and 
induction of some of its target genes including SOD and heme oxygenase (54,73). These 
studies also show that NRF2 deficiency increases noise-induced injury and hearing loss, while 
its induction has protective effects (54,73). 
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Exposure to particulate matter (PM) 
Like other forms of environmental stress, exposure to PM results in activation of NRF2 and 
increased transcription of its target genes (48,77). Not only NRF2 induces transcription of 
antioxidant genes but also in phase 2 enzymes of xenobiotic metabolism. As a consequence, 
NRF2 deficiency increases the genotoxic actions of diesel exhaust (6). This has led to the 
suggestion that the levels of expression of NRF2 target genes could represent markers of 
exposure to PM (196). Because NRF2 also regulates secondary effects of environmental 
pollutants, such as inflammation and allergy, the NRF2 response to PM could also be used to 
predict those at risk of developing asthma (104), cardiovascular disease and atherosclerosis 
(99). 
 
Mental stress  
Recent studies have correlated depression, typically caused by mental stress and social 
defeat, with low grade chronic inflammation that affects critical regions of the brain (14). 
NRF2 modulates inflammation by down-regulating the NF-NB pathway (41,78). Additionally, 
NRF2 inhibits expression of IL-6 and IL-1E by directly binding the proximal promoter of these 
genes (90). Nrf2-knockout mice exhibit a depressive-like behaviour, with reduced levels of 
dopamine and serotonin and increased levels of glutamate in the prefrontal cortex, altered 
levels of proteins associated to depression such as VEGF and synaptophysin, as well as 
microgliosis. Importantly, depressive-like behaviour elicited by endotoxin in wild-type mice 
could be attenuated with the NRF2 activator sulforaphane (114).  
 
Ionizing and UV-radiation 
Exposure to cosmic, ionising radiations and UV radiation, either from natural sources of from 
devices, represents a significant challenge to homeostatic redox mechanisms and nucleic 
acids integrity. Recent studies have demonstrated that NRF2 promotes DNA repair and drives 
detoxification of superoxide that is generated after irradiation (158). In particular, NRF2 
regulates the expression of RAD51, many DNA repair genes, including those of homologous 
recombination repair pathway, and have putative antioxidant response elements (80).  
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NOISE INDUCED HEARING LOSS 
 
Noise-induced hearing loss (NIHL) can be induced by exposure to loud sound. Affected 
individuals may have inability to hear certain frequencies of sound, cognitive impairment of 
sound perception, including sensitivity to sound and ringing in the ears (tinnitus) (1). The 
association between noise exposure and hearing loss was first recognized by Sir Francis Bacon 
(1561-1626) (65).  
NIHL is caused by acute (e.g. sudden exposure to loud noise, explosion) or chronic acoustic 
trauma (e.g. loud music). NIHL is the most common occupational disease and its severity 
differs amongst individuals, and increases with age, compromising the quality of life that 
extend beyond hear loss. Unfortunately, unlike birds and amphibians, ability to regenerate 
hearing is lost in mammals. Thus, in human beings any damage to the hearing organ from any 
sound source over time leads to permanent hearing loss.  
Cochlea is located within the inner ear and houses the specialized peripheral end organ of the 
auditory system, which mediates the transduction of sound waves into electrical nerve 
impulses that travel to the brain for central processing of auditory information. Acoustic 
insults to the cochlea cause mechanical and metabolic changes affecting almost all cell types, 
but particularly the sensory hair cells and neurons. Temporary and permanent threshold 
shifts occur from mechanical and metabolic changes caused by the exposure to different 
noise levels (34,70,92,95,100).  Mechanical damages occur with exposure to the noise levels 
of 115-125 dB sound pressure level (SPL), while metabolic damages occur with exposure to 
the noise level of less than 115 dB SPL. These changes in threshold shifts are related to noise-
induced neural degeneration, which begins shortly after noise exposure and can progress for 
several years post exposure (94,119) Importantly, early noise exposure can intensify age-
related hearing loss (94).  
Beginning at 85 dB (~300 times the energy level of 60 dB), long or repeated exposures may 
result in a notable loss of hearing. This level of 85 dB and above includes some everyday 
sounds, for example, music on personal listening devices or emanating from small machinery 
such as lawnmowers. Noise coming from urban traffic, household appliances, personal 
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listening devices or occupational noise can also elicit hearing loss. Importantly, long or 
repeated exposure to moderate noise levels is often associated with alterations in behavior, 
as well as changes in neuroendocrine, cardiovascular and immune systems (45,189). Cochlear 
damage and hearing loss associated with chronic environmental noise exposure may be 
linked to an increase in ROS levels as well as inflammatory processes in the cochlea.  
 
 
Noise induced hearing loss - pathology 
Early studies of NIHL demonstrated mechanical damages of the cochlear structures including 
the disruption of Reissner’s and basilar membranes, damage and loss of stereocilia bundles, 
damage of the inner and outer hair cells (IHCs, OHCs), stria vascularis, spiral ganglion cells, 
and lateral wall of the OHCs (23,92,100,168). OS and inflammation are major contributors to 
NIHL. 
Cell death induced by acoustic overexposure occurs primarily through apoptosis and necrosis. 
Apoptosis is a programmed cell death, with no inflammatory response (70). As discussed 
below, the apoptosis can be mediated by the activity of enzymes, induced by increased 
production of ROS (ROS) and Reactive Nitrogen Species (RNS) (92,129,188). The second cell 
death pathway is necrosis, a passive unprogrammed cell death which is identified by swollen 
and pale-staining cytoplasm resulting in rupture of the cell, spillage of the cell contents, 
damage to surrounding tissue, and evocation of an inflammatory response (70). Both 
apoptotic and necrotic pathways have been observed in the cochlea immediately after noise 
exposure (76), as discussed below and illustrated in Figure 5.  
 
OS induced apoptosis in hearing loss 
The cochlea is a highly metabolically active sensory organ, which receives 0.5 mL per minute 
of blood flow in normal conditions (92). Metabolically, noise exposure can decrease cochlear 
blood flow leading to cochlear ischemia-reperfusion injury, induce cell death by producing 
ROS, and contribute to injury and death of hair cells and spiral ganglion cells (33,70,92). Noise-
induced OS causes lipid peroxidation in the spiral ganglion, organ of Corti, and stria vascularis, 
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leads to oxidation of actin filaments of stereocilia and cell membrane lipids, protein oxidation, 
damage to nuclear and mitochondrial DNA, swelling and degeneration of afferent nerve 
endings, and release of toxic lipid peroxidation products such as 4-hydroxy 2, 3-nonenal (HNE) 
(51,92).  
 
OS biomarkers in hearing loss 
OS occurs immediately and is present up to 30 days following noise exposure (70,200). In the 
first 10 days, the formation of ROS reaches its peak (200). OS has been identified by a variety 
of biomarkers of ROS and RNS activity in the cochlea and the brain (51). These biomarkers 
include HNE, nitrotyrosine (NT), malondialdehyde (MDA), inducible nitric oxide synthase 
(iNOS), cytochrome-C, caspase-3, 8, 9, and p66shc. Formation of HNE was observed after 
noise exposure in the lateral wall and Claudius cells, the Deiter’s cells and the outer hair cell 
bodies (33,51,200). Formation of NT, a biomarker of NO production formed by nitration of a 
tyrosine residue in proteins, occurs in the hair cells after noise exposure (33,51,200).  MDA 
was observed in cochlea immediately after noise exposure (33). The expression of iNOS in the 
hair cells, wall of the blood vessels of stria vascularis and marginal cells was observed 
immediately after noise exposure (160). Noise exposure induces cytochrome-C release from 
mitochondria and caspase-3, -8, or -9 activation in both apoptotic and necrotic OHCs, while 
caspase activation occurred only in apoptotic OHCs  (129). Another important issue is the 
cause of ROS production in NIHL. Animal studies have shown that local application of NADPH 
oxidase (NOX) inhibitors has protective effects (21) and a genome-wide association study (98) 
showed that NOX3 is critical in the development of NIHL.  These studies led to the suggestion 
of a potential therapeutic approach to inner ear pathologies (150). 
 
Inflammatory biomarkers in hearing loss 
Acoustic trauma can also initiate inflammation in the stria vascularis, compromising blood 
supply to the cochlea, causing hypoxia and injury to HCs (166). Injuries to the stria vascularis 
and spiral ligament occur following noise trauma, damaging type II and IV fibrocytes leading 
to permanent hearing loss (71). 
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As a response to acoustic trauma, the cochlear cells express cytokines, such as TNF-α and IL-
1β, and chemokines, which cause leukocyte migration (86). These inflammatory cells, 
producing cytokines, chemokines, ROS and RNS, then propagate the inflammatory process to 
the inner ear.  
Following acoustic trauma, an influx of inflammatory cells occurs (71,173,174,186).  These 
cells are mostly found in the spiral ligament (type I, III and type IV fibrocytes), and in the 
perilymph of the scala tympani and scala vestibule (71,173,174,186).). IL-6 immunoreactive 
cells were observed initially in the cytoplasm of type III and IV fIbrocytes, then throughout 
the spiral ligament and the stria vascularis (58). Double labelling with the neuronal marker 
NeuN showed IL-6 expression in the spiral ganglion neurons after noise exposure. 
Chemokines (such as MCP-1/CCL2, MCP-5/CCL12, and MIP-1β/CCL4) are upregulated by 
acoustic trauma (174). ICAM-1/CD54, a vascular adhesion molecule that mediates leukocyte 
extravasation, as well as other adhesion molecules including P-selectin, PECAM-1 and VCAM-
1, are also increased after noise exposure (161,174,199).  
The measurement of cytokines as biomarkers on inflammation in hearing loss may have 
translational implication. For instance, the IL-1 receptor antagonist drug anakingra improves 
hearing loss associated with autoinflammatory diseases (120) and autoimmune diseases, 
including in glucocorticoid-resistant patients (181). 
 
BRAIN-BODY INTERACTIONS OF STRESS, OS AND INFLAMMATION 
 
While stress and inflammation are often implicated in disease, there is a bidirectional 
regulation between the two. Figure 6 outlines the main regulatory pathways. The classical 
pathway is mediated by glucocorticoids (GC). The fact that stress activates the hypothalamus 
pituitary adrenal axis (HPAA) to increase GC has been known for a long time, and GC are 
probably the oldest anti-inflammatory drugs. The finding that GC inhibit the expression of 
inflammatory cytokines provided an important mechanism of action (20). It soon became 
clear that inflammatory cytokines activate the HPAA and thus increase GC that not only inhibit 
cytokine synthesis but also protect from their toxicity, in a classical feedback (18,19,35,179). 
This raises an important point in the interpretation of the scheme in Figure 6: inflammatory 
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cytokines and inflammation are also stressors themselves, sometime defined as “immune 
stressors”. 
It comes therefore as no surprise that corticosteroids are used as biomarkers of stress. 
Because their level in the blood vary with time, the measurement of hair cortisol, which 
accumulates over weeks and months, has been proposed as a biomarker of stress (117) and 
has been successfully used in the study of post-traumatic stress disorder (PTSD) (111). More 
recent studies have identified in the cholinergic response mediated by vagus nerve 
stimulation another mechanism of regulation of peripheral inflammation by the brain, which 
also led to development of novel therapeutic options (133,177). 
The fact that infection induces a sickness behaviour (lethargy, anorexia, social isolation) is an 
old observation, but findings by Dantzer (reviewed in (47)) that this is mediated by cytokines 
has provided a molecular mechanism for what is thought to be an adaptive response of the 
organism to better survive an infection (46).  Similar to their effect on IL-1-induced lethality 
(19), GC inhibit the anorexigenic response to IL-1 (140), indicating that they act not only by 
inhibiting cytokine production but also their action.  
As we mentioned earlier, OS can induce inflammation and, vice-versa, inflammation induces 
OS. This has been hypothesized to be the case in PTSD, where a study measuring levels of 
inflammatory cytokines and markers of OS suggests that inflammatory cytokines induce ROS 
production, which then amplifies the inflammatory response (194). 
Fitting GC and the HPAA in this bi-directional autostimulatory loop between inflammation 
and OS is more difficult. Clearly GC, by blocking production of inflammatory cytokines, could 
remove a major stimulus of OS. On the other hand, activation of the HPAA, by increasing 
metabolic rate and glucose availability, can result in increased OS (167) and, in agreement 
with this hypothesis, administration of corticosterone to rats causes an increase in biomarkers 
of OS, lipid peroxides and protein carbonyls (153).  
It should be pointed out, however, that the latter study, as well as the study on PTSD cited 
earlier (194) were performed measuring, among other biomarkers, superoxide levels in 
plasma and blood. Because, as mentioned above, superoxide has a half-life in milliseconds, 
some aspects of the methodological approach might be questioned. 
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Effect of emotional states on OS and inflammation 
Emotions, inflammation and OS share three fundamental features: 1- they help the host to 
adjust to different environmental challenges and maintain a status of homeostasis; 2- they 
can have both protective or deleterious effects for the host; 3- they are deeply intertwined in 
ways that we have only started to appreciate and are not fully explored. The few examples 
below should be sufficient to support these statements.  
There is evidence that basic emotions, like laughter and joy, improve immunological 
competence of host through NK cells, important in cancer surveillance (60). It is possible that 
the negative emotional state often experienced following a diagnosis of cancer might 
contribute to the development of this disorder, and that ‘laughing therapy’ (60) and patient 
support groups might have a biological therapeutic value for cancer patients undergoing 
chemotherapy.  
Negative emotions (anger and rage) can be protective as they represent an immediate 
reaction to real or imaginative dangers but also contribute to the exacerbation of chronic 
inflammatory diseases (25,88). Anger, rage and aggressive behaviour cause a significant 
increase in the serum levels of IL-1 (136). 
Several studies (11,26,32,42,43,113,138) have highlighted the link between emotion and 
immunity.  
Studies have shown how external conditions (massage-like stroking or enriched environment) 
can improve the host resilience to immunosuppression (107,138).  
We think that the implications of these studies go beyond the simple duality of emotions and 
immunity as an example of body-mind continuum. Indeed, the “mirroring effect” that we 
have proposed to explain how emotions influence immune response and vice-versa 
(26,42,43) might as well work for another system.  
There is increasing evidence that emotional state and personality affects inflammation and 
OS. Interestingly, several risk factors for cardiovascular disease (CVD) (high fat diet, sedentary 
lifestyle and smoking) are associated with elevated OS, and are lifestyle choices associated 
with depression (7,97). 
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Many recent studies highlighted links between outlook on life and outcome in disease. For 
example, people who have Type D personality, a pessimistic and socially inhibited outlook, do 
worse during CVD. Heart failure patients with this personality type have elevated levels of 
xanthine oxidase (XO) and reduced heat shock protein 70. These factors combined might 
increase OS and inflammation, leading to a worse prognosis (89). On the other hand, higher 
optimism correlates with lower levels of inflammation, IL-6, and markers of endothelial 
dysfunction. Similarly, there is a positive correlation between higher optimism scores and 
increased carotenoid and antioxidant levels, suggestive that optimists may have lower OS 
(22). 
These studies might help with the stratification of patients based on their personality traits. 
People who practice meditation have lower levels of lipid peroxidation in serum but higher 
levels of NO, which is indicative of normalized endothelial function (69). The risk of all-cause 
mortality, stroke and myocardial infarction can be lowered by as much as 45%, due to a 
reduction in psychosocial stress and in blood pressure which are both linked to OS (151). 
Similarly, yoga seems to attenuate OS possibly increasing glutathione reductase (GR) and 
glutathione peroxidase (GPx) and decreasing serum lipid peroxides and F2-isoprostane. Yoga 
practice in type 2 diabetics decreases MDA, increase GSH and vitamin C and improve 
glycaemic control (66). However, studies done in this area are small and therefore should be 
interpreted with caution until larger randomised clinical trials are done. 
Social isolation is an increasingly worrying threat, as socially isolated people are at increased 
risk of several diseases including atherosclerosis and dementia (56,157). Social isolation 
downregulates the genes required for the glucocorticoid response, which could impair ability 
to dampen immune responses, and inflammation is exacerbated by increased expression of 
NF-κB (38). Similarly, in rats who have been chronically isolated OS is observed, accompanied 
by decreased GPx and GR (49). 
Opposed to social isolation, environmental enrichment normalises levels of TNF-α, CCL3 and 
CCL4 by preventing changes in microglial expression in Alzheimer’s Disease models (184), and 
lowers hippocampal damage and OS during chronic cerebral hypoperfusion (113).  
Most animal models of environmental enrichment use physical exercise. Depressed patients 
who exercise have lower markers of OS (155). In rats, GSH depletion causes anxiety-like 
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behaviour, while moderate exercise on a treadmill prevents OS-induced anxiety and 
decreasing OS markers in the hippocampus, amygdala and the locus coeruleus (146).  
 
Biomarkers of OS and inflammation in mental disorders 
There is a lot of clinical evidence to support a role of oxidative stress and inflammation in 
mental disorders. Depression causes elevated total oxidative stress in plasma and serum with 
increased plasma NO levels associated with suicidal thoughts (88,101). Depressive patients 
are found to have lower total antioxidant activity (TAA) with scores being indicative of poor 
response to pharmacological treatments (13). A meta-analysis study looking at CRP, IL-1, IL-6 
found that these factors were positively correlated with depression (75). Serum TNF-D and 
CRP are elevated during depression and treatment with SSRIs returned levels to that seen in 
non-depressed patients and this was associated with decreased clinical scores of depression 
(178).  In social phobia patients, studies have shown that alongside having increased MDA 
there was increased SOD, GSH-Px and catalase and lipid peroxidation. Interestingly, a positive 
correlation was seen between anxiety levels and MDA, SOD and GSH-Px as well as a positive 
correlation between MDA, SOD and CAT and the duration of illness (10).CRP levels are 
elevated in men who have anxiety disorders and are higher in those who have late onset 
anxiety disorders (>50 years) but no difference in TNF-D and IL-6 (184). 
 
THE HUMAN EXPOSOME 
 
Proposed by Wild in 2005 as an environmental counterpart to the human genome, the human 
exposome represents the totality of environmental (i.e. non-genetic) exposure individual 
experiences between conception and death (191). As a “comprehensive description of 
lifelong exposure history” (192) the exposome effectively provides a new framework for 
bringing together interdisciplinary teams to understand the environmental determinants of 
chronic disease risk, the influence of which are estimated to exceed those relating to genetic 
predisposition (144).  Wild subsequently elaborated on his definition of the exposome, 
emphasising the dynamic nature of exposures over a lifetime and categorising components 
of the exposome into three domains; internal, specific external and general external (192). 
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Specific reference was made to factors that influence the internal or cellular environment 
(e.g. metabolism, ageing, gut microflora activity), vary at the individual level (e.g. occupation, 
lifestyle components, mental stress, noise, air pollutants) or influence populations (e.g. 
climate, education, urban/rural surroundings) (192). The definition was also expanded to 
include behavioural interactions and products of endogenous exposure (e.g. epigenetic 
changes), and to account for the cumulative nature of exposures and their corresponding 
biological adaptations (118). While there have been several proposed revisions of this original 
definition, the practical implementation of this general concept has led researchers to 
embrace more holistic and integrated methods for assessing the external and internal 
environments. Central to the implementation of this idea is the application of data-dense 
omics techniques that report on various aspects of the internal chemical milieu (in most cases 
focused on the blood) to provide complementary datasets relating to biochemical status in 
individual biosamples. Combined with access to mature biobanking resources, the recent 
radical advances in molecular biology approaches, multivariate data analysis tools, 
biomonitoring technology, and the proliferation of inexpensive mobile devices have enabled 
exposome studies to become a reality. The exposome proposal came in response to the 
limitations in epidemiological studies attempting to link environmental exposure assessments 
with disease endpoints – effectively ‘bottom-up’ approaches, focused on a small number of 
priority exposures. By contrast, exposome studies seek to benefit from ‘top-down’, data-
driven, agnostic approaches that can uncover previously unknown and/or complex 
relationships, as well as guide subsequent hypothesis-based investigations to provide 
mechanistic insight about disease aetiology. Complete characterisation of the exposome - 
which would require high-resolution, real time monitoring of all exposures throughout life - 
is clearly unfeasible for multiple obvious reasons (8). However, it is proposed that 
understanding the status of the exposome, particularly that of the internal chemical 
environment, at the individual level during critical periods of life may help delineate the 
contributions of various genetic and environmental factors. 
 
Studying the exposome 
An improved ability to characterise the external chemical environment can enhance exposure 
models both spatially and temporally, but it is the extensive characterisation of internal 
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chemical environment that represents the most significant advance in recent years, and an 
opportunity to delineate the contributions made by multiple, interacting factors, to the 
biological changes observed at an individual level. High-throughput platforms now exist for 
profiling the metabolome (metabolites), proteome (proteins), transcriptome (gene 
transcripts) and adductome (typically endogenous-xenobiotic conjugates) and provide 
collectively a wealth of information about the status of a biological samples (reviewed in the 
context of the human exposome by (193), summarised briefly in Table 2). These platforms 
(mostly, now) provide broad coverage of their biomolecular target classes, and therefore 
permit the application of data-driven approaches that mirror those used in the genome-wide 
association studies (GWAS). The techniques may be performed on cells, tissues or biofluids, 
making novel biomarker selection possible for in vitro, in vivo and human studies and 
integrated analyses may be performed across the omics platforms to cross-validate or 
integrate findings. Initial studies have indicated that suitably collected/stored biobanked 
samples are amenable to analysis by multiple omics platforms (68), and large scale initiatives 
to conduct exposome studies are now underway (including the EXPOsOMICS (182), HELIX 
(185), and HEALS (http://www.heals-eu.eu) projects in the EU). 
 
Unpicking the exposome: cellular inflammatory responses to diesel exhaust particles 
While there is considerable activity in molecular epidemiological analysis to characterise 
biological samples archived in biobanks, the validation and mechanistic understanding that 
accompanies these largely correlative analyses is both complementary and vital; tying 
together evidence from multiple levels of analysis is required to corroborate the correlative 
analyses that are conducted on these omics readouts (144,182). For example, while many of 
the ongoing exposome studies include aspects concerning air pollutants, validation of these 
studies requires a coherent molecular context, while conversely targeted analyses need to be 
directed appropriately. For example, diesel exhaust particles (DEP) are considered important 
environmental causes of OS and pulmonary inflammation due to their ubiquitous presence in 
air (84), their concentration in populated areas (206) and the breadth of sub-populations that 
are susceptible to their inflammatory and oxidative effects (12,17,27,37,53).  Adverse 
responses to DEP exposure have traditionally been assessed by quantifying specific 
inflammatory cells, cytokines or cell adhesion molecules (CAM) following exposures 
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(2,93,127,152,175). These targets are well characterised mediators of inflammation that 
provide strong evidence of DEP induction of inflammatory cellular response, but are limited 
in their potential to expand our mechanistic knowledge of the observed toxicity. In contrast, 
agnostic approaches for omics screening report on both characterised and uncharacterised 
markers, offering chances to explore a wider range of associations with DEP toxicity. Xiao et 
al used a proteomic screening approach, showing that DEP induced OS in RAW 264.7 
macrophages; the response was accompanied by > 8-fold increases in new protein 
expression. Furthermore, the biological functions of the proteins reflected a hierarchical 
response to OS with the macrophages expressing antioxidant enzymes after low dose 
exposures (≤ 10 µg/ml), pro-inflammatory signalling proteins after mid dose exposures (10-
50 µg/ml) and regulators of mitochondrial function at cytotoxic doses (≥ 50 µg/ml) (198). 
Although many of these proteomic changes validated existing hypotheses of how 
macrophages respond to DEP, others (including the induction of receptor-induced apoptosis) 
were previously uncharacterised (198). These changes revealed novel pathways that are 
triggered by DEP-induced OS, advancing our understanding of the response.  
Metabolomic, transcriptomic, and proteomic profiles are strongly dependent on the 
expression and behaviour of the other molecular species as well as experiencing a dynamic 
interaction with the external chemical environment (Figure 7). Proteomic response to DEP-
induced OS (198) are mirrored by transcriptomic studies showing changed expression of 
oxidative response genes after DEP exposure (91,134) as well as micro RNA (miRNA) (79).   
Supporting the hypothesis that surface bound metals and polycyclic aromatic hydrocarbons 
(PAHs) contribute to particulate toxicity (87,135), metal and PAH-rich heavy fuel oil (HFO) 
particles induce inflammatory and OS pathways more than carbonaceous DEP (130).  
Redox status, inflammation and ROS are all intricately linked with biotransformation of 
compounds across this continuum. For example, dietary components have been linked with 
modulation of cytokine levels, with concomitant impact on the metabolome (36), with other 
recent examples including herbal medicine (205), involvement in arthritis (reviewed by 
Chimenti et al. (31)), and broader implication in pathways identified by cross-omics analysis 
(16,163). Additionally, a comprehensive survey focused on the role of metabolome studies in 
characterising oxidative studies was previously published by Liu et al (108). 
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Exposome and Adverse Outcome Pathways: inflammation and ROS are key integrators of 
complex exposure-response relationships 
One exemplar that elegantly illustrates the interplay of inflammatory mediators and ROS with 
other components of the internal chemical milieu, is the analgesic/antipyretic compound 
paracetamol (a.k.a. acetaminophen), one of the most commonly used over-the-counter drugs 
worldwide. Self-administration is the main cause for personal exposure (exposure in the 
wider environment is negligible), and large-scale, cross-sectional metabolic phenotyping 
studies of humans have shown a high prevalence of significant (e.g. therapeutic dose) 
exposure (109,110). Characterising population-level use of therapeutics (e.g. anti-
inflammatory agents) provides an overall profile of the exposome, and help contextualise and 
validate observed responses at the individual level (e.g. when addressing research questions 
relating to chronic inflammation that may be confounded by unreported pharmaceutical use). 
Intense scrutiny has allowed many of the toxicological consequences of paracetamol 
exposure and metabolism be elucidated (including depletion of cellular antioxidants, 
increased ROS formation, formation of reactive intermediates). However, despite such 
widespread, long-term and consistent use, the complexities of the exposure-response 
relationship continue to be uncovered (including metabolite conjugation to arachidonic acid 
to produce an active metabolite AM404 (72) and metabolite modulation of the nociceptive 
response (4). This also illustrates the challenge that is faced when considering how to dissect 
the complex, multicomponent exposures that occur throughout life; considerations of 
additive or non-linear effects arising from co-exposures all add up. 
Attempts to bring together the diverse pieces of evidence that relate to exposure-response-
disease relationships, and address the challenge of this inherent complexity have resulted in 
the formulation of systems toxicology tools such as adverse outcome pathways (AOPs), as 
summarised by Burden et al. (28). By establishing a series of causal steps from an initial 
molecular initiating event (MIE) onwards, the AOP approach may help integrate knowledge 
about multiple environmental exposures that share common pathways, described using an 
agreed ontology. The combination of the exposome and AOP frameworks is likely to be 
particularly useful when the complexity of exposure-response relationships is considered; 
exposures do not occur in isolation, but in a context that encodes previous exposures and 
responses, and mediates the dynamic relationship between co-exposures.  
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In the context of oxidative stress, several redox proteomics techniques and their application 
to the field of inflammation and neuroinflammation have led to the identification of specific 
oxidized proteins undergoing carbonylation (170) or glutathionylation (30,122). The 
extension of omics to oxidative post-translational modifications may add a dimension to the 
information obtained and eventually provide a more precise way of identifying exposure to 
agents that cause oxidative stress. 
The strong underlying biological network connections between certain sets of pathologies - 
particularly those relating to systemic inflammatory status that underpin multiple chronic 
disease conditions - may mean we move away from attempts to find correspondence 
between individual exposures and outcomes, and towards using biological networks to link 
and explain complex exposure patterns with (multi)morbidities defined by detailed molecular 
phenotyping (102,169). 
 
CONCLUSIONS 
 
The use of biomarkers of inflammation or OS has been instrumental to formulating causal 
hypotheses on disease mechanisms (such as the effect of environmental stressors).  
We mentioned above that, in a way, biomarkers are signs. However, there are different types 
of signs and so, if biomarkers really are signs in a non-metaphorical sense, there must be 
different types of biomarkers as well, depending on the relation they have with their referent. 
In fact, we don’t just measure biomarkers, in some cases we can measure the “real thing”. 
For instance, to quantify exposure to heavy metals we can measure their level in the 
organism. When this is not possible, we can measure signs that are indicators of the exposure 
of the body to heavy metals. Some of them have a direct relationship to the object, for 
example a product of lipid peroxidation is directly formed by a chemical reaction between a 
ROS and a lipid. Others can be an indicator of the response of the organism to the object we 
want to measure, and this is the case of NRF2 or the markers of exposure described in the 
section on the exposome; all these will have various degrees of separation from the object 
we want to measure and this needs to be considered as some may require just transcription 
(if we measure a mRNA), others transcription and translation (if we measure a protein). This 
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is particularly important if we are measuring exposure to a physical stressor, such as noise, or 
a psychological stressor, that is not present at the time of the examination. 
Interestingly, even if not obvious, inflammation itself is a response to a foreign body or to an 
endogenous of exogenous stressor. It is important to note that measuring biomarkers is not 
always a second, imperfect choice when we cannot measure what we need (like in the case 
of short-lived radicals). Often measuring a biological response adds a second dimension, that 
of biological relevance. But in the case of inflammatory biomarkers, we observe a further level 
of relevance. 
Let us consider inflammatory cytokines. As we wrote earlier, they are easily measurable 
biomarkers of inflammation, many of which measurable in plasma or serum. However, some 
of them are not simple signs but proxies. A proxy of something is a sign that has a vicarious 
relation with that something: it both “stands for” its referent and “stands in for” it. This means 
that not only there is a link between proxy and referent; one can also interact with the 
referent by operating on the proxy and, as a result, affect the object (or process, in this case) 
it stands for (55). In short, they have a bidirectional relationship with the referent. If MDA is 
elevated in a disease because of increased lipid peroxidation, you cannot improve the disease 
by administering an anti-MDA antibody, because it is just a sign of OS. However, in 
inflammatory diseases IL-6 and TNF-α are not only signs of the inflammatory process but 
proxies, and so their inhibition, for instance with antibodies, improves the disease in patients 
with chronic inflammation. This concept is exemplified in Figure 8 where the mediators and 
processes described in this paper are assigned a value of biomarker (considering their ease of 
measurement) or proxies. Researchers often classify biomarkers differently. For instance, 
MDA, IL-6 and TNF would be considered mechanism-based biomarkers because they reflect 
a potential disease mechanism. On the other hand, IL-6 and TNF are also defined as 
“pharmacological targets”, although not all pharmacological targets are biomarkers as some 
of them are not measurable. The definition of biomarkers as signs and their value, whether 
they are proxies or just signs, will need to be considered when considering their role in 
disease. 
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ABBREVIATIONS 
AOP, adverse outcome pathway 
ARE, antioxidant response element 
CAM, cell adhesion molecules 
CCL, CC chemokine ligand 
CNT, carbon nanotubes 
CVD, cardiovascular disease 
DEP, diesel exhaust particles 
ENM, engineered nanomaterials 
EpRE, Electrophile Responsive Element 
GC, glucocorticoids 
GSH, reduced glutathione 
GSK-3, Glycogen synthase kinase 3 
GSSG, oxidized glutathione 
GWAS, genome-wide association studies  
HC, hair cells 
HFO, heavy fuel oil 
HNE, hydroxy-2-nonenal 
HPAA, hypothalamus-pituitary adrenal axis 
IHC, inner hair cells 
IL-, interleukin 
iNOS, inducible nitric oxide synthase 
KEAP1, Kelch-like ECH-associated protein 1 
MAF, musculoaponeurotic fibrosarcoma oncogene homolog 
MAPK, mitogen-activated protein kinase 
MDA, malondialdehyde 
MIE, molecular initiating event 
NF-kB, nuclear factor kappa B 
NIHL, Noise-induced hearing loss 
NLP3, NACHT, LRR and PYD domains-containing protein 3  
NRF2, nuclear factor (erythroid-derived 2)-like 2 
NT, nitrotyrosine 
OHC, outer hair cells 
OS, oxidative stress 
P2X7R, purinergic receptor P2X7 
PAH, polycyclic aromatic hydrocarbons 
PRDX, peroxiredoxin  
PTSD, post-traumatic stress disorder 
RNS, reactive nitrogen species 
ROS, reactive oxygen species 
SPL, sound pressure level 
TNF, tumor necrosis factor 
TXN, thioredoxin 
TXNIP, thioredoxin-interacting protein 
UPS, ubiquitin/proteasome system  
XO, xanthine oxidase 
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Table 1. Inflammasome activation induced by particles vs. engineered nanomaterials 
Material Main findings References 
MSU crystals NLRP3-dependent induction of IL-1E release in vitro (115) 
Cholesterol crystals Cholesterol crystals activate NLRP3 and induce IL-1E production in human 
macrophages 
(52,143) 
Hydroxyapatite crystals Induction of IL-1E and IL-18 production in mouse macrophages is induced by needle-
like and clumped nanocrystals, but not spherical and larger crystals, and depends on 
potassium efflux, generation of ROS, and lysosomal damage/cathepsin B in vitro, and 
on various NLRP3 components in vivo (KO mice) 
(83) 
Crystalline silica Crystalline silica induces NLRP3 activation and IL-1E production through 
phagolysosome destabilization 
(50,74,195) 
Amyloid E Induction of IL-1E release in vitro in LPS-primed primary mouse microglial cells, NLRP3 
inflammasome-dependent, ATP-dependent 
(61) 
 
Asbestos Asbestos induces NLRP3 inflammasome activation in vitro (human primary 
macrophages), dependent on ROS production, cathepsin B activity, P2X7 receptors 
and Src/Syk kinases 
(50,132) 
Aluminum salts Aluminum salts induce NLRP3 activation and IL-1E production through phagolysosome 
destabilization 
(74) 
CeO2 nanowires of various size Correlation between nanowires’ length and lysosomal damage, cathepsin B release 
and IL-1E release in vitro (human THP-1) 
(81) 
Polystyrene and PLG nanospheres Smaller particles are taken up better by mouse BMDC in vitro and induce more IL-1E 
release, in a NLRP3-, cathepsin B- and phagosomal acidification-dependent manner 
(159) 
Silver nanospheres Smaller particles induce IL-1E release in monocytes better than larger ones, 
dependent on mitochondrial superoxide, cathepsin release and K+ efflux. 
(201) 
TiO2 nanobelts Induction of IL-1E release in vitro by long but not by short or spherical particles 
(human THP-1, murine alveolar macrophages)  
(62) 
TiO2 nanospheres Phagocytosis-independent induction of IL-1E release in vitro (mouse BMDM, human 
THP-1 and primary keratinocytes). Smaller particles more active than larger ones in 
murine DC, in an actin-, ROS-, NLRP3-, and caspase-1-dependent fashion. 
(195,203) 
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SiO2 nanospheres Phagocytosis-independent induction of IL-1E release in vitro (mouse BMDM, human 
THP-1 and primary keratinocytes). Amorphous silica NPs induce IL-1E production in 
mouse DC in an actin-, ROS-, NLRP3-, and caspase-1-dependent fashion. 
(195,203) 
Carbon nanotubes Long CNT induce NLRP3 inflammasome activation in vitro (human primary 
macrophages), dependent on ROS production, cathepsin B activity, P2X7 receptors 
and Src/Syk kinases 
(132) 
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Table 2. Summary of common omics approaches in exposome studies 
Omics Target 
Molecule  
Analytical Platform Typical 
Profile 
Content 
(~ # of 
molecules) 
Advantages and limitations of technique 
Transcriptome Gene 
transcripts 
Microarray 
 
 
 
 
Next generation 
sequencing 
<50,000 
 
 
 
 
Full 
transcriptome 
Custom arrays available 
Suitable for cellular, tissue and biofluid samples 
Limited target number 
Limited detection limit 
 
High sensitivity (single nucleotide level) 
Low limit of detection 
Qualitative and quantitative  
Suitable for cellular, tissue and biofluid samples 
High cost 
Proteome Proteins Mass spectrometry 
 
 
 
 
Protein array 
 
 
 
 
 
>20,000 
High throughput, specificity and sensitivity 
Qualitative and quantitative  
Multiple methods required to cover proteome 
Complex feature annotation 
 
High throughput and sensitivity 
Low sample consumption 
Efficient feature annotation  
Limited target number 
Metabolome Small molecule 
metabolites 
Nuclear magnetic 
resonance spectroscopy 
(1H NMR) 
 
 
>100 
 
 
 
 
Minimal sample preparation 
Suitable for cellular, tissue and biofluid samples 
Metabolite annotation/assignment typically 
straighforward  
Suitable for cellular, tissue and biofluid samples 
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Liquid chromatography - 
Mass spectrometry  
(LC-MS) 
>1000 Derivatisation required for polar and high molecular 
weight metabolites 
Metabolite annotation/assignment can be time-
consuming 
Adductome 
(serum 
albumin) 
Endogenous-
xenobiotic 
conjugates 
Mass spectrometry >100 Ability to capture information on reactive 
intermediates and/or short-lived exposures 
Variety of techniques available for targeting with 
different specificity and resolution 
Time-consuming annotation  
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FIGURE LEGENDS 
 
Figure 1. The semiotic triad according to Peirce. Images from Wikimedia Commons. 
 
Figure 3. The three-tiered paradigm of OS induced by nanomaterials at the single cell level.  
 
Figure 4. The three-pronged response of complex living systems to nanomaterials.  
 
Figure 4. Regulation of NRF2 by protein stability. A, KEAP1/NRF2 interaction. Thiol reactive 
groups in KEAP1 provide a mechanism for sensing the levels of ROS and electrophiles. B, β-
TrCP/GSK-3/NRF2 interaction. Phosphorylation of NRF2 by GSK-3 provides a layer of 
regulation by signaling pathways and by electrophilic compounds and alter the balance 
kinase/phosphatase, exemplified here with PTEN (modified from (154)). 
 
Figure 5.  Mechanisms of ototoxicity induced by acoustic trauma. 
 
Figure 6. The main neuroendocrine-immune pathways. 
 
Figure 7. Interactions between genes and the environment are mediated by a complex 
network of biological entities. Environmental exposures occur in the context of all previous 
exposures and the multifactorial responses elicited by the biological network.  Characterising 
the biological complexity of the internal chemical milieu during key periods of life (e.g. small 
molecules that constitute the metabolic phenotype; status of gene expression; etc.) using 
high-throughput omics platforms provides a window on the human exposome, and an 
opportunity to start dissecting the contributions of various factors to the etiology of chronic 
diseases. 
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Figure 8. Biomarkers for stress-induced inflammation and OS. The symbols denote 
whether the biomarker is a sign (that indicates the activation of a process) or a proxy (that 
are also targets we can interact with to modify the disease process). 
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